US2004180837A1PendingUtilityA1
Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
Est. expiryMar 14, 2023(expired)· nominal 20-yr term from priority
A61K 47/6949A61P 7/00A61P 7/06B82Y 5/00C07D 487/22
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A porphyrin compound represented by general formula (A): Also disclosed are a porphyrin metal complex-albumin inclusion compound having a porphyrin compound, in which M denotes Fe or Co, included in albumin, and an artificial oxygen carrier containing the porphyrin metal complex-albumin inclusion compound as an active component.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A porphyrin compound represented by general formula (A):
where R 1 denotes a C 1 -C 18 alkyloxy group, a C 1 -C 18 alkylamino group, or a peptide having 1-6 α-amino acids and having a hydroxyl group, a benzyl oxy group or a methoxy group at the C-terminal; R 2 denotes a residual group after removal of an amino group and a carboxyl group from an α-amino acid; R 3 denotes a C 1 -C 18 alkyloxy group, a C 1 -C 18 alkylamino group, or a peptide having 1-6 α-amino acids and having a hydroxyl group, a benzyloxy group or a methoxy group at the C-terminal; each R 4 and each R 5 denote either a methyl group, or a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, a 1-bromoethyl group or a formyl group, wherein, where each R 4 denotes a methyl group, each R 5 denotes a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, 1-bromoethyl group or a formyl group, and where each R 4 denotes a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxyethyl group, a 1-bromoethyl group or a formyl group, each R 5 denotes a methyl group; M denotes two hydrogen atoms bonded to the two pyrrole nitrogen atoms or an ion of a transition metal belonging to the fourth to fifth periods in the Periodic Table; X − denotes a halogen ion that is present where M denotes the transition metal ion; and n which denotes the number of X is the number obtained by subtracting 2 from the valency of the transition metal ion.
2 . The porphyrin compound according to claim 1 , wherein each R 4 denotes a hydrogen atom, a vinyl group, an ethyl group, a 1-methoxy ethyl group, a 1-bromo ethyl group or a formyl group, and each R 5 denotes a methyl group.
3 . The porphyrin compound according to claim 1 , wherein each R 4 denotes a methyl group, and each R 5 denotes a vinyl group, an ethyl group, a 1-methoxy ethyl group, a 1-bromo ethyl group or a formyl group.
4 . The porphyrin compound according to claim 1 , wherein M denotes Fe or Co.
5 . The porphyrin compound according to claim 4 , wherein Fe is divalent or trivalent.
6 . The porphyrin compound according to claim 4 , wherein Co is divalent.
7 . A porphyrin metal complex-albumin inclusion compound having the porphyrin compound defined in claim 4 included in albumin.
8 . An artificial oxygen carrier comprising the porphyrin metal complex-albumin inclusion compound defined in claim 7 as an active component.Join the waitlist — get patent alerts
Track US2004180837A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.